Trial · NCT05511246
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ventricular tachycardia recurrence | 0-12 months | Detection of VT on defibrillator |
| Primary | Hospitalization for cardiac causes | 0-12 months | |
| Primary | Severe procedural complications | 0-12 months | Severe procedural complications include bleeding requiring transfusion, stroke or systemic embolization, pericardial tamponade, myocardial infarction, and vascular complications requiring surgery, plus cardiogenic shock requiring unplanned mechanical support. |
| Primary | Death | 0-12 months | |
| Secondary | Procedural time | During procedure | Total procedure time (minutes) |
| Secondary | Need for unplanned mechanical hemodynamic support | During procedure | Unplanned use of intra-aortic balloon pump or ventricular assist device during procedure (Yes/No) |
| Secondary | Repeat ablation procedures, including epicardial | 0-12 months | Need for repeat procedure (Yes/No) |
| Secondary | All-cause mortality | 0-12 months | |
| Secondary | Appropriate ICD therapies: antitachycardia pacing and ICD shocks | 0-12 months | Presence of appropriate ICD therapies on interrogation |
| Secondary | Inappropriate ICD therapies: antitachycardia pacing and ICD shocks | 0-12 months | Presence of inappropriate ICD therapies on interrogation |
| Secondary | Change in ICD therapies compared to 3-months pre-randomization | 0-12 months | Comparison of number of therapies on ICD interrogation |
| Secondary | Vt storm | 0-12 months | More than 2 episodes of VT within a 24h period |
| Secondary | Sustained VT below detection rate | 0-12 months | |
| Secondary | Change in left ventricular ejection fraction (percent) | Before and 3 months post-procedure | Measured before and 3 months after procedure |
| Secondary | Quality of life measurement using SF-32 questionnaire | 0-12 months | Scores range from 0 - 100; Lower scores = more disability, higher scores = less disability |
| Secondary | Hospital admission for cardiac causes (including heart failure exacerbation) | 0-12 months | Hospitalization due to cardiac arrhythmia, heart failure exacerbation and other cardiac causes (yes/no) |
| Secondary | Antiarrhtyhmic therapy | 0-12 months | Number of antiarrhythmic drugs before and after ablation |
| Secondary | Freedom from VT after repeat procedures | 0-12 months | Recurrence of VT (yes/no) including patients that have multiple ablations |
| Secondary | Cardiac transplant or left ventricular assist device implantation | 0-12 months | As a measure of deterioration of cardiac status, requirement of transplant of ventricular assist device implant (yes/no) will be compared |
| Secondary | Fluoroscopy time | During procedure | Total time of fluoroscopy use (minutes) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05511246/registered